Published in Medical Letter on the CDC and FDA, December 10th, 2006
Jim Charlton, president of Miraculins, said Miraculins has had initial communication with the FDA, and now appoints Hogan & Hartson in recognition of the advancing state of the company's diagnostic test. Further, the company is now finalizing the preferred sales and distribution strategy for its...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA